0001214659-19-003910.txt : 20190530
0001214659-19-003910.hdr.sgml : 20190530
20190530202629
ACCESSION NUMBER: 0001214659-19-003910
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190529
FILED AS OF DATE: 20190530
DATE AS OF CHANGE: 20190530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Boehm Rainer J.
CENTRAL INDEX KEY: 0001732381
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35798
FILM NUMBER: 19868249
MAIL ADDRESS:
STREET 1: C/O HUMANIGEN, INC.
STREET 2: 1000 MARINA BOULEVARD, SUITE 250
CITY: BRISBANE
STATE: CA
ZIP: 94005-1878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HUMANIGEN, INC
CENTRAL INDEX KEY: 0001293310
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770557236
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 533 AIRPORT BLVD.
STREET 2: SUITE 200
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650.243.3100
MAIL ADDRESS:
STREET 1: 533 AIRPORT BLVD.
STREET 2: SUITE 200
CITY: BURLINGAME
STATE: CA
ZIP: 94010
FORMER COMPANY:
FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20040609
4
1
marketforms-45106.xml
PRIMARY DOCUMENT
X0306
4
2019-05-29
0001293310
HUMANIGEN, INC
HGEN
0001732381
Boehm Rainer J.
C/O HUMANIGEN, INC.
533 AIRPORT BOULEVARD, SUITE 400
BURLINGAME
CA
94010
true
false
false
false
Common Stock, $0.001 par value
2019-05-29
4
A
false
238625
0.665
A
317184
D
Stock Option (Right to Buy)
0.665
2019-05-29
4
M
false
238625
0
D
2018-06-30
2028-03-08
Common Stock
238625
477252
D
The option vests in 12 ratable quarterly installments commencing June 30, 2018.
/s/ Cameron Durrant, Attorney-in-Fact
2019-05-30